VVTM.V VVT Med Inc.
- Market cap
- CAD 10.9M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is VVTM.V undervalued?
Graham numberThe Graham number of VVT Med Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
VVT Med Inc. fundamental analysis
No fundamental analysis for VVT Med Inc. yet.
VVT Med Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.
Full company profileVVT Med Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
VVT Med Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 81.0K | 41.0K | 492K | 89.0K | 174K |
| Gross Profit | 7.00K | 5.00K | 374K | 63.0K | 106K |
| Operating Income | -2.25M | -1.75M | -1.10M | -4.94M | -2.25M |
| EBITDA | -2.28M | -1.75M | -537K | -3.36M | -2.16M |
| Net Income | -2.59M | -2.20M | -1.04M | -3.98M | -2.23M |
| EPS | -0.04 | -0.03 | -0.02 | -0.06 | -0.03 |
| Balance Sheet | |||||
| Total Assets | 885K | 889K | 985K | 916K | 829K |
| Total Liabilities | 4.43M | 6.25M | 7.37M | 2.74M | 2.66M |
| Shareholders' Equity | -3.54M | -5.36M | -6.38M | -1.82M | -1.83M |
| Cash & Short-term Investments | 151K | 71.0K | 104K | 145K | 9.00K |
| Cash Flow | |||||
| Operating Cash Flow | -1.93M | -1.40M | -911K | -3.16M | -1.78M |
| Capital Expenditure | 19.0K | 1.00K | 0.00 | 4.00K | 2.00K |
| Free Cash Flow | -1.95M | -1.40M | -911K | -3.17M | -1.78M |
| Ratios | |||||
| ROA | -293.1% | -247.0% | -105.6% | -434.1% | -269.0% |
| Net Profit Margin | -3,202.5% | -5,356.1% | -211.4% | -4,467.4% | -1,281.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
VVT Med Inc. dividends
VVT Med Inc. has not paid dividends in the last 4 fiscal years.
Last stock split: 214:1000 on Jul 31, 2025.
Who owns VVT Med Inc.
- Insiders 15.83%
- Institutions 0.00%
- Public & others 84.17%
- Shares outstanding 72.6M
- Free float 61.1M
VVT Med Inc. company profile
- Company name
- VVT Med Inc.
- Ticker
- VVTM.V
- Exchange
- TSX Venture Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 8
- Fiscal year end
- December
- Address
- Hasadna 6 st., Kfar Saba, Israel, 4442405
- Phone
- 972 9 766 0480
- Website
- vvtmed.com
About VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.
VVT Med Inc. management
5- Mr. Erez TetroCEO & Director
- Mr. Dor SnehCFO & Corporate Secretary
- Mr. Gideon VitkonChief of Operations
- Ms. Orly EfratyVice President of Global Marketing
- Eyal AlonVice President of Global Sales